vs
Side-by-side financial comparison of First Bancorp, Inc (FNLC) and Invivyd, Inc. (IVVD). Click either name above to swap in a different company.
First Bancorp, Inc is the larger business by last-quarter revenue ($25.8M vs $17.2M, roughly 1.5× Invivyd, Inc.). First Bancorp, Inc runs the higher net margin — 39.4% vs -64.3%, a 103.7% gap on every dollar of revenue. On growth, Invivyd, Inc. posted the faster year-over-year revenue change (24.5% vs 17.5%).
Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.
Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.
FNLC vs IVVD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.8M | $17.2M |
| Net Profit | $10.2M | $-11.1M |
| Gross Margin | — | — |
| Operating Margin | 48.1% | -73.0% |
| Net Margin | 39.4% | -64.3% |
| Revenue YoY | 17.5% | 24.5% |
| Net Profit YoY | 39.7% | 40.0% |
| EPS (diluted) | $0.91 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.8M | $17.2M | ||
| Q3 25 | $24.5M | $13.1M | ||
| Q2 25 | $22.5M | $11.8M | ||
| Q1 25 | $21.8M | $11.3M | ||
| Q4 24 | $22.0M | $13.8M | ||
| Q3 24 | $20.5M | $9.3M | ||
| Q2 24 | $19.2M | $2.3M | ||
| Q1 24 | $18.5M | $0 |
| Q4 25 | $10.2M | $-11.1M | ||
| Q3 25 | $9.1M | $-10.5M | ||
| Q2 25 | $8.1M | $-14.7M | ||
| Q1 25 | $7.1M | $-16.3M | ||
| Q4 24 | $7.3M | $-18.4M | ||
| Q3 24 | $7.6M | $-60.7M | ||
| Q2 24 | $6.2M | $-47.2M | ||
| Q1 24 | $6.0M | $-43.5M |
| Q4 25 | 48.1% | -73.0% | ||
| Q3 25 | 45.2% | -84.0% | ||
| Q2 25 | 43.7% | -127.8% | ||
| Q1 25 | 39.3% | -149.7% | ||
| Q4 24 | 39.5% | -139.1% | ||
| Q3 24 | 44.6% | -670.0% | ||
| Q2 24 | 38.8% | -2175.2% | ||
| Q1 24 | 39.3% | — |
| Q4 25 | 39.4% | -64.3% | ||
| Q3 25 | 37.0% | -79.7% | ||
| Q2 25 | 35.8% | -124.4% | ||
| Q1 25 | 32.5% | -144.1% | ||
| Q4 24 | 33.1% | -133.5% | ||
| Q3 24 | 36.9% | -653.1% | ||
| Q2 24 | 32.1% | -2086.9% | ||
| Q1 24 | 32.5% | — |
| Q4 25 | $0.91 | $0.02 | ||
| Q3 25 | $0.81 | $-0.06 | ||
| Q2 25 | $0.72 | $-0.12 | ||
| Q1 25 | $0.63 | $-0.14 | ||
| Q4 24 | $0.66 | $-0.14 | ||
| Q3 24 | $0.68 | $-0.51 | ||
| Q2 24 | $0.55 | $-0.40 | ||
| Q1 24 | $0.54 | $-0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $226.7M |
| Total DebtLower is stronger | $95.5M | — |
| Stockholders' EquityBook value | $283.1M | $241.5M |
| Total Assets | $3.2B | $276.9M |
| Debt / EquityLower = less leverage | 0.34× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $226.7M | ||
| Q3 25 | — | $85.0M | ||
| Q2 25 | — | $34.9M | ||
| Q1 25 | — | $48.1M | ||
| Q4 24 | — | $69.3M | ||
| Q3 24 | — | $106.9M | ||
| Q2 24 | — | $147.9M | ||
| Q1 24 | — | $189.4M |
| Q4 25 | $95.5M | — | ||
| Q3 25 | $95.5M | — | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $70.0M | — | ||
| Q4 24 | $95.0M | — | ||
| Q3 24 | $95.0M | — | ||
| Q2 24 | $70.0M | — | ||
| Q1 24 | $70.0M | — |
| Q4 25 | $283.1M | $241.5M | ||
| Q3 25 | $274.6M | $93.1M | ||
| Q2 25 | $265.5M | $42.8M | ||
| Q1 25 | $259.7M | $54.1M | ||
| Q4 24 | $252.5M | $67.5M | ||
| Q3 24 | $256.8M | $83.2M | ||
| Q2 24 | $244.7M | $140.6M | ||
| Q1 24 | $242.6M | $178.5M |
| Q4 25 | $3.2B | $276.9M | ||
| Q3 25 | $3.2B | $139.2M | ||
| Q2 25 | $3.2B | $89.1M | ||
| Q1 25 | $3.2B | $103.7M | ||
| Q4 24 | $3.2B | $129.5M | ||
| Q3 24 | $3.1B | $161.9M | ||
| Q2 24 | $3.1B | $177.3M | ||
| Q1 24 | $3.0B | $215.5M |
| Q4 25 | 0.34× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.36× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.38× | — | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.29× | — | ||
| Q1 24 | 0.29× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $37.8M | $-15.5M |
| Free Cash FlowOCF − Capex | $34.6M | — |
| FCF MarginFCF / Revenue | 133.9% | — |
| Capex IntensityCapex / Revenue | 12.5% | 0.0% |
| Cash ConversionOCF / Net Profit | 3.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | $55.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.8M | $-15.5M | ||
| Q3 25 | $12.9M | $-8.3M | ||
| Q2 25 | $7.4M | $-13.3M | ||
| Q1 25 | $2.2M | $-21.1M | ||
| Q4 24 | $26.0M | $-37.6M | ||
| Q3 24 | $9.8M | $-41.1M | ||
| Q2 24 | $6.4M | $-41.6M | ||
| Q1 24 | $-1.5M | $-50.2M |
| Q4 25 | $34.6M | — | ||
| Q3 25 | $12.6M | — | ||
| Q2 25 | $7.2M | $-13.3M | ||
| Q1 25 | $828.0K | $-21.3M | ||
| Q4 24 | $24.6M | $-37.6M | ||
| Q3 24 | $9.6M | $-41.1M | ||
| Q2 24 | $6.3M | — | ||
| Q1 24 | $-1.8M | $-50.4M |
| Q4 25 | 133.9% | — | ||
| Q3 25 | 51.4% | — | ||
| Q2 25 | 32.1% | -112.9% | ||
| Q1 25 | 3.8% | -188.2% | ||
| Q4 24 | 111.7% | -272.2% | ||
| Q3 24 | 47.0% | -441.6% | ||
| Q2 24 | 32.9% | — | ||
| Q1 24 | -9.8% | — |
| Q4 25 | 12.5% | 0.0% | ||
| Q3 25 | 1.2% | 0.0% | ||
| Q2 25 | 0.6% | 0.1% | ||
| Q1 25 | 6.2% | 1.3% | ||
| Q4 24 | 6.7% | 0.0% | ||
| Q3 24 | 0.5% | 0.1% | ||
| Q2 24 | 0.3% | 0.0% | ||
| Q1 24 | 1.8% | — |
| Q4 25 | 3.72× | — | ||
| Q3 25 | 1.42× | — | ||
| Q2 25 | 0.91× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 1.29× | — | ||
| Q2 24 | 1.03× | — | ||
| Q1 24 | -0.25× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
